Principal Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Principal Securities's BMY Position: Q1 2026 in Review
Principal Securities increased its Bristol-Myers Squibb (BMY) stake by 9.8% in Q1 2026, buying an estimated $326K and bringing the position to 62,512 shares worth $3.79M. The position accounts for 0.06% of the portfolio, ranked #319.
Principal Securities first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Principal Securities held 62,512 shares of Bristol-Myers Squibb worth $3.79M as of Q1 2026.
- Principal Securities bought 5,585 Bristol-Myers Squibb shares in Q1 2026, an estimated $326K.
- Bristol-Myers Squibb made up 0.06% of Principal Securities's portfolio in Q1 2026, its #319 holding.
- Principal Securities first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.